Hydroxypropyl cellulose capsule shell

Details for Australian Patent Application No. 2009256572 (hide)

Owner Glaxo Group Limited

Inventors McAllister, Stephen Mark; Margetson, Daniel N.; Russell, Danielle Genevieve Rebecca; Matthews, Wayne M.; Brown, Adrian

Agent Davies Collison Cave

Pub. Number AU-A-2009256572

PCT Pub. Number WO2009/150228

Priority 61/061,275 13.06.08 US

Filing date 12 June 2009

Wipo publication date 17 December 2009

International Classifications

A61K 9/48 (2006.01) Medicinal preparations characterised by special physical form - Preparations in capsules, e.g. of gelatin, of chocolate

Event Publications

6 January 2011 PCT application entered the National Phase

  PCT publication WO2009/150228 Priority application(s): WO2009/150228

15 December 2011 Assignment before Grant

  Glaxo Group Limited The application has been assigned to Capsugel Belgium NV

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009256574-2,4'-bipyridinyl compounds as protein kinase D inhibitors useful for the treatment of IA heart failure and cancer

2009256566-Improved protein expression system